HOME › DRUGS › LASOFOXIFENE
ACTIVE SUBSTANCE / INN

LASOFOXIFENE

Brand name(s): Fablyn
EMA LISTED
LAPSED
Osteoporosis, Postmenopausal
ACTIVE SUBSTANCE
Lasofoxifene
REGULATORS
EMA
SPONSORS / MAH
Dr. Friedrich Eberth Arzneimittel GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FablynDr. Friedrich Eberth Arzneimittel GmbHLapsed24/02/2009Osteoporosis, Postmenopausal

FULL INTELLIGENCE ON LASOFOXIFENE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →